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Identity 
Other names: TRAP150 
HGNC (Hugo): THRAP3 
Location: 1p34.3 
Local order: See NCBI and Ensembl. 
DNA/RNA 
Description 
The THRAP3 gene contains 12 exons with the size of 
80942 bases. 
Transcription 
This gene has 4 transcripts (according to Ensembl). 
Pseudogene 
3 pseudogene are found (Review record(s) in Gene). 
Protein 
Description 
TRAP150 contains an arginine/serine (RS)-rich 
sequence in the N-terminal region, while its C-terminal 
region has 48% overall identity with BCLAF1, a cell 
death-promoting transcriptional repressor bcl2-
associated factor (Ito et al., 1999; Kasof et al., 1999). 
Notably, BCLAF1 also contains an RS domain in the 
N-terminus.  
Based on the high similarity between TRAP150 and 
BCLAF1, these two proteins constitute a gene family. 
Within the BCLAF1 homologous domain of TRAP150, 
a segment of ~90 amino acids shares 30% similarity 
with MLN51, which is a core component of the exon 
juction complex (Macchi et al., 2003).  
Biochemical identification of proteins with 
phosphorylated residues has revealed that TRAP150 is 
likely phosphorylated protein (Beausoleil et al., 2004; 
Beausoleil et al., 2006; Olsen et al., 2006; Matsuoka et 




TRAP150 is primarily localized in the nucleoplasm and 
accumulated in some punctuate foci, albeit excluded 
from the nucleoli.  
The speckled structures of TRAP150 are colocalized 
with the splicing factor SC35. Using the heterokaryon 
assay, TRAP150 was demonstrated to be a nuclear-
restricted protein, while it is associated with the mRNA 
export receptor TAP (Lee et al., 2010).  
The mouse TRAP150, like its human homolog, was 
also detected in nuclear speckles, especially, under 




TRAP150 was initially identified as a subunit of the 
TRAP (thyroid hormone receptor associated 
protein)/Mediator complex (Ito et al., 1999). Moreover, 
it was also detected in a group of proteins that were 
associated with the tail of histone H3 and H4 (Choi et 
al., 2007; Heo et al., 2007). However, whether 
TRAP150 participates in the transcription regulation is 
poorly documented. 
Splicing  
TRAP150 contains an RS domain and is associated 
with several precursor mRNA (pre-mRNA) splicing 
factors (Li et al., 2003; Lee et al., 2010).  
Moreover, TRAP150 was also reported to interact with 
the domains that provide links between transcription 
and splicing, such as the WW domains of pinin and the 
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FF domains of CA150 (Smith et al., 2004; Ingham et 
al., 2005).  
Therefore TRAP150 has been proposed to function in 
coupling of transcription and pre-mRNA processing 
(Auboeuf et al., 2005).  
This possibility was supported by independent 
biochemical analyses of mRNA ribonucleoprotein 
(mRNP) complexes. Firstly, TRAP150 was identified 
as a component of mRNPs; its association with mRNAs 
was splicing- and cap-binding complex (CBC)-
independent (Merz et al., 2007).  
Moreover, TRAP150 was detected in the spliceosomal 
complex B, which is a fully assembled splicing 
complex prior to the catalytic step of splicing 
(Bessonov et al., 2008; Wahl et al., 2009). Finally, 
experimental evidence showed that overexpression of 
TRAP150 activated the splicing of a reporter pre-
mRNA, while knockdown of TRAP150 impaired the 
splicing (Lee et al., 2010), indicating the role of 
TRAP150 in facilitating pre-mRNA splicing.  
Other pre-mRNA processing events 
TRAP150 and its analog BCLAF1 are associated with 
SNIP1 (Smad nuclear interacting protein 1), pinin and 
SkIP (Ski-interacting protein) to form the SNIP1/SkIP-
associated RNA processing (SNARP) complex. The 
SNARP regulates the expression level of cyclin D1 
probably by recruiting U2AF65 to its pre-mRNA 
(Bracken et al., 2008; Witzel et al., 2010).  
To date, whether TRAP150 is directly involved in 
alternative pre-mRNA splicing still remains to be 
investigated. However, TRAP150 may modulate 
splicing through protein-protein interactions. In resting 
T cells, TRAP150 binds to phosphorylated PTB-
associated splicing factor (PSF), which results in steric 
hindrance of the RNA recognition motifs of PSF. Upon 
T cell activation, de-phosphorylated PSF is dissociated 
from TRAP150 and therfore could regulate the 
alternative splicing of CD45 transcripts (Heyd et al., 
2010). 
In addition to splicing, TRAP150 may participate in 
mRNA degradation. When tethered to a reporter 
precursor mRNA, TRAP150 could promote the 
degradation of the spliced mRNA, which occurs in a 
translation-independent manner and in the nucleus (Lee 
et al., 2010). 
Homology 
Homologous genes of TRAP150 are found in 
chimpanzee, dog, cow, mouse, rat, chicken and 
zebrafish (homologs of the THRAP3 gene). 
Implicated in 
Note 
See t(1;17)(p34;p13) in aneurysmal bone cyst. 
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